PROCORALAN

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Ireland, Italy, Lithuania, Mexico, Netherlands, Poland, Spain, Tunisia, UK.

Active ingredients

The drug PROCORALAN contains one active pharmaceutical ingredient (API):

1	Ivabradine UNII TP19837BZK - IVABRADINE HYDROCHLORIDE
	Ivabradine is a pure heart rate lowering agent, acting by selective and specific inhibition of the cardiac pacemaker If current that controls the spontaneous diastolic depolarisation in the sinus node and regulates heart rate. The cardiac effects are specific to the sinus node with no effect on intra-atrial, atrioventricular or intraventricular conduction times, nor on myocardial contractility or ventricular repolarisation.
	Read more about Ivabradine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PROCORALAN Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01EB17	Ivabradine	C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	531302101111218, 531302102118216, 531302103114214, 531302104110212
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00434721, 00434738, 00673087, 01688122, 01689110, 02256778, 03879151, 03879814, 03880556, 03880579, 05389310, 06441403, 06441426, 07577754, 10004795, 10004803, 10004826, 10130850, 10203218, 10321053, 10321076, 10321082, 10402426, 10526051, 10554515, 10554538, 11214170, 11226799, 11258210, 11542595, 12381295, 12389279, 13862513, 15266301, 15619774, 16031681, 16031698, 17368968, 17421421
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.819-11-07, 27.872-10-07
EE	Ravimiamet	1219463, 1219474, 1219485, 1219496, 1219508, 1219519, 1219520, 1219531, 1219542, 1219553, 1219564, 1219575, 1219586, 1219597
ES	Centro de información online de medicamentos de la AEMPS	05316003, 05316003IP, 05316003IP1, 05316010, 05316010IP, 05316010IP1, 05316010IP2
FI	Lääkealan turvallisuus- ja kehittämiskeskus	041086, 041096, 041105, 041114
FR	Base de données publique des médicaments	61952527, 63501124
GB	Medicines & Healthcare Products Regulatory Agency	375319, 381637, 381639, 98303, 98306
IE	Health Products Regulatory Authority	42703, 42704, 42706, 42710, 42720, 42721, 42725, 42774
IT	Agenzia del Farmaco	037061013, 037061025, 037061037, 037061049, 037061052, 037061064, 037061076, 037061088, 037061090, 037061102, 037061114, 037061126, 037061138, 037061140
LT	Valstybinė vaistų kontrolės tarnyba	1030448, 1030449, 1030450, 1030451, 1030452, 1030453, 1030454, 1030455, 1030456, 1030457, 1030458, 1030459, 1030460, 1030461
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	204M2007
NL	Z-Index G-Standaard, PRK	198161, 198188
PL	Rejestru Produktów Leczniczych	100147059, 100147065
TN	Direction de la Pharmacie et du Médicament	6353171, 6353172